Affiliation:
1. The Center for Healthcare Ethics, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, U.S.A.
Abstract
Vascularized composite allotransplantation (VCA) is the name most often used to refer to the transplantation of anatomical units composed of multiple tissue types (skin, bone, muscle, tendon, nerves, vessels, etc.) when such transplants do not have the primary purpose of extending life, as is the case in the more familiar field of solid organ transplantation (SOT). A serious interest in VCA developed in the late twentieth century following advances in immunosuppression which had led to significant improvements in short and medium-term survival among SOT recipients. Several ethical concerns have been raised about VCA, with many being connected in one way or another to the limitations, burdens, and risks associated with immunosuppression. This article will focus on upper extremity and craniofacial VCA, beginning with a brief review of the history of VCA including reported outcomes, followed by a discussion of the range of ethical concerns, before exploring in greater detail how immunological issues inform and shape several of the ethical concerns.
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology
Reference77 articles.
1. Allograft vasculopathy after allogeneic vascularized knee transplantation;Transpl. Int.,2011
2. History and ethics of hand transplants;JRSM Short Rep.,2012
3. Successful hand transplantation—one-year follow-up;N. Engl. J. Med.,2000
4. Kleinert Kutz Hand Care Center Media Relations. World's Most Successful Hand Transplant Recipient Celebrates 20th Anniversary. http://handtransplant.com/ForNewsMedia/tabid/59/Default.aspx?GetStory=1754. Accessed March 26, 2019
5. Outcomes after hand and upper extremity transplantation;J. Mater. Sci. Mater. Med.,2017
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献